| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/NBDI.1999.0251 |
| P698 | PubMed publication ID | 10600406 |
| P2093 | author name string | Roses AD | |
| Higgins G | |||
| Catsicas S | |||
| Boschert U | |||
| Merlo-Pich E | |||
| P433 | issue | 6 | |
| P921 | main subject | excitotoxicity | Q901117 |
| P304 | page(s) | 508-514 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Neurobiology of Disease | Q15716606 |
| P1476 | title | Apolipoprotein E expression by neurons surviving excitotoxic stress | |
| P478 | volume | 6 |
| Q34034409 | APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease |
| Q48549149 | Abnormalities of the hippocampus are similar in deoxycorticosterone acetate-salt hypertensive rats and spontaneously hypertensive rats |
| Q37060457 | Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities. |
| Q35794576 | Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene |
| Q28576453 | Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors |
| Q22248091 | Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease |
| Q34497951 | Apolipoprotein E: From lipid transport to neurobiology |
| Q28265290 | Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease |
| Q33532794 | Apolipoprotein-E forms dimers in human frontal cortex and hippocampus |
| Q34680878 | Apolipoproteins in the brain: implications for neurological and psychiatric disorders |
| Q37705204 | CSF Apo-E levels associate with cognitive decline and MRI changes |
| Q35978742 | Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice |
| Q42045406 | Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice |
| Q34635216 | Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development |
| Q36504889 | Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). |
| Q44267254 | Effect of domain interaction on apolipoprotein E levels in mouse brain. |
| Q60949811 | Effects of Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease |
| Q34951817 | Function and comorbidities of apolipoprotein e in Alzheimer's disease |
| Q34604101 | Genetics of Alzheimer disease |
| Q48483832 | Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment |
| Q45993868 | Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. |
| Q40015743 | Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS. |
| Q37954450 | Modeling the dementia epidemic. |
| Q28383537 | Neighborhood psychosocial environment, apolipoprotein E genotype, and cognitive function in older adults |
| Q44795511 | Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. |
| Q33906823 | Pharmacogenetics and the practice of medicine |
| Q46529938 | Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. |
| Q41771621 | Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E. |
| Q30500121 | Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors |
| Q91733029 | The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease |
| Q28576515 | Toxicogenomic studies of the rat brain at an early time point following acute sarin exposure |
| Q27497836 | Unique aspects of transcriptional regulation in neurons - nuances in NFkappaB and Sp1-related factors |
Search more.